# A unified theory of thin film and bulk bilayer nickelates

Preprint · Jiangfan Wang, Yi-feng Yang

- Archive id: arxiv:2606.04821
- Published: 2026-06-03
- arXiv: https://arxiv.org/abs/2606.04821
- Citations: 0
- Source URL: https://arxiv.org/abs/2606.04821
- PDF: https://arxiv.org/pdf/2606.04821
- Provenance: arxiv

## Abstract

The discovery of bilayer nickelate superconductivity in both pressurized bulk and thin films has drawn enormous attention on their similarity and distinction. Here we provide a unified explanation based on the two-component scenario for a number of key experimental observations reported recently. Our theory predicts two superconducting domes upon electron or hole doping, separated by a valence bond state near $d\_{z^2}$ half filling for strong interlayer superexchange coupling $J$, and a single dome across half filling with a lower $T\_c$ for weak or moderate $J$. Increasing doping drives the normal state from a Fermi liquid to non-Fermi liquid or weak insulating behaviors, with quasi-linear-in-$T$ scattering rate near optimal $T\_c$, while breaking the interlayer valence bonds by oxygen vacancies or chemical substitution simultaneously suppresses the superconductivity and causes local Kondo scattering of $d\_{x^2-y^2}$ electrons. These explain the different superconducting transitions and normal states in bulk and thin films, the effect of $d\_{z^2}$ hole or electron doping, and the Kondo effect in non-superconducting samples. We propose bulk superconductivity at ambient pressure by doping or reducing the interlayer magnetic coupling and predict even higher $T\_c$ upon electron doping.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Nickelate & Iron-Based Superconductors](https://space-kitty.com/topics/nickelates-iron-based)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.